Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience

scientific article published in January 1994

Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF02213694
P698PubMed publication ID7949832

P2093author name stringR A Lobo
M V Sauer
R J Paulson
P2860cites workLeuprolide acetate: serum and follicular fluid concentrations and effects on human fertilization, embryo growth, and granulosa-lutein cell progesterone accumulation in vitroQ39605817
Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patientsQ41143467
The effect of leuprolide acetate on steroidogenesis by granulosa and theca cells in vitroQ41851247
Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studiesQ45084121
In vitro fertilization in unstimulated cycles: a clinical trial using hCG for timing of follicle aspirationQ45221996
Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: A preliminary reportQ45289789
The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal womenQ46055577
In vitro fertilization in unstimulated cycles: the University of Southern California experienceQ46269823
Factors affecting pregnancy success of human in-vitro fertilization in unstimulated cyclesQ46604170
The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-GluQ46725463
Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer GroupQ67979093
In vitro fertilization without ovarian stimulation: a simplified protocol applied in 80 cyclesQ69549792
Natural cycle in vitro fertilization-embryo transfer at the University of Ottawa: an inefficient therapy for tubal infertilityQ72853223
P433issue1
P1104number of pages5
P304page(s)28-32
P577publication date1994-01-01
P1433published inJournal of Assisted Reproduction and GeneticsQ15755113
P1476titleAddition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience
P478volume11

Reverse relations

cites work (P2860)
Q36515505FSH and folliculogenesis: from physiology to ovarian stimulation
Q40793256Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment
Q41548204Stress-related Disturbances of the Menstrual Cycle
Q36268258The utility of serum progesterone and inhibin A for monitoring natural-cycle IVF-ET.

Search more.